Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$27,000.00

2024 CGS-M Application

EF 2024-25

Résumé
By 2030, 1% of all Canadians will be living with inflammatory bowel diseases (IBD), a group of chronic inflammatory conditions that has no cure. IBD is diagnosed and monitored through colonoscopies, which require bowel preparation (prep) to clear out the intestinal tract. While safer in healthy individuals, bowel prep can trigger negative outcomes such as flare-ups in patients with IBD. In this patient population, the ecosystem of microbes in the gut, termed the gut microbiota, differs from that of healthy individuals and harbours pathobionts, microbes that can act as pathogens under certain conditions.My goal is to elucidate how IBD-associated pathobionts exploit the post-bowel prep high-osmolality gut environment to invade the host and cause inflammation. To closely recapitulate human in vivo intestinal physiology and environment, I developed a bowel-prep model using human intestinal cells cultured on microfluidic gut-on-a-chip devices. To achieve this goal, I will co-culture human intestinal epithelial and immune cells with an IBD microbiota and characterize the effect of bowel prep on pathobiont-host interactions. I will assess key outcomes, including gut inflammation, epithelial permeability, and pathobiont translocation across the gut barrier. Following this, I will test the ability of a natural osmoprotectant, betaine, to alleviate host inflammation and pathobiont translocation following bowel prep.My study seeks to explore novel host-microbiota interactions in IBD and provide insights into microbial mechanisms that contribute to IBD pathology. These findings have the potential to guide future therapies and enhance clinical outcomes for IBD patients undergoing bowel prep.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
529818
Name
Deng Brian D
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
2024 CGS-M Application
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bowel Preparation; Flow Cytometry; Fluorescent Microscopy; Gut Microbiota; Gut-On-A-Chip; Host-Microbe Interactions; Hyperosmotic Stress; Inflammatory Bowel Disease; Intestinal Permeability; Organoid Culture
Abstract
By 2030, 1% of all Canadians will be living with inflammatory bowel diseases (IBD), a group of chronic inflammatory conditions that has no cure. IBD is diagnosed and monitored through colonoscopies, which require bowel preparation (prep) to clear out the intestinal tract. While safer in healthy individuals, bowel prep can trigger negative outcomes such as flare-ups in patients with IBD. In this patient population, the ecosystem of microbes in the gut, termed the gut microbiota, differs from that of healthy individuals and harbours pathobionts, microbes that can act as pathogens under certain conditions.My goal is to elucidate how IBD-associated pathobionts exploit the post-bowel prep high-osmolality gut environment to invade the host and cause inflammation. To closely recapitulate human in vivo intestinal physiology and environment, I developed a bowel-prep model using human intestinal cells cultured on microfluidic gut-on-a-chip devices. To achieve this goal, I will co-culture human intestinal epithelial and immune cells with an IBD microbiota and characterize the effect of bowel prep on pathobiont-host interactions. I will assess key outcomes, including gut inflammation, epithelial permeability, and pathobiont translocation across the gut barrier. Following this, I will test the ability of a natural osmoprotectant, betaine, to alleviate host inflammation and pathobiont translocation following bowel prep.My study seeks to explore novel host-microbiota interactions in IBD and provide insights into microbial mechanisms that contribute to IBD pathology. These findings have the potential to guide future therapies and enhance clinical outcomes for IBD patients undergoing bowel prep.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Deng, Brian D
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~